Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK8 | P45983 | 1/20 | 0.39 |
| ▸ | EP300 | Q09472 | 1/20 | 0.38 |
| ▸ | KAT2A | Q92830 | 1/20 | 0.38 |
| ▸ | KAT2B | Q92831 | 1/20 | 0.38 |
| ▸ | RORA | P35398 | 2/20 | 0.37 |
| ▸ | RORC | P51449 | 2/20 | 0.37 |
| ▸ | RORB | Q92753 | 2/20 | 0.37 |
| ▸ | TSPO | P30536 | 2/20 | 0.37 |
| ▸ | HSD11B1 | P28845 | 2/20 | 0.36 |
| ▸ | ICMT | O60725 | 1/20 | 0.34 |
| ▸ | PGR | P06401 | 2/20 | 0.33 |
| ▸ | PLA2G4A | P47712 | 1/20 | 0.33 |
| ▸ | LTB4R2 | Q9NPC1 | 1/20 | 0.32 |
| ▸ | DHODH | Q02127 | 1/20 | 0.32 |
| ▸ | PSMB5 | P28074 | 1/20 | 0.32 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.32 |
| ▸ | CTSV | O60911 | 1/20 | 0.32 |
| ▸ | CTSL | P07711 | 1/20 | 0.32 |
| ▸ | CNR1 | P21554 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL262630 | 0.98 | EP300 (0.39) | MAPK8EP300KAT2AKAT2BRORA | |
| SCHEMBL10161081 | 0.96 | MAPK8 (0.38) | MAPK8EP300KAT2AKAT2BRORA | |
| SCHEMBL14029408 | 0.96 | RORA (0.38) | MAPK8EP300KAT2AKAT2BRORA | |
| SCHEMBL10161132 | 0.95 | MAPK8 (0.36) | MAPK8EP300KAT2AKAT2BRORA | |
| SCHEMBL10175858 | 0.94 | TSPO (0.36) | MAPK8EP300KAT2AKAT2BRORA | |
| SCHEMBL262076 | 0.92 | TSPO (0.37) | EP300KAT2AKAT2BRORARORC | |
| SCHEMBL262206 | 0.92 | EP300 (0.43) | MAPK8EP300KAT2AKAT2BRORA | |
| SCHEMBL14521315 | 0.91 | RORA (0.39) | MAPK8EP300KAT2AKAT2BRORA | |
| SCHEMBL13620181 | 0.91 | HSD11B1 (0.42) | MAPK8EP300KAT2AKAT2BRORA | |
| SCHEMBL10160294 | 0.90 | PLA2G4A (0.35) | MAPK8RORARORCRORBTSPO |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8288012-B2 | Anthracene derivatives and light-emitting devices using the anthracene derivatives | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2012-10-16 | — | — | US | disclosed |
| US-8288012-B2 | Anthracene derivatives and light-emitting devices using the anthracene derivatives | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2012-10-16 | — | — | US | disclosed |
| US-20120211728-A1 | Light-Emitting Element, Light-Emitting Device, and Electronic Appliance | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. | 2012-08-23 | — | — | US | disclosed |
| US-8101289-B2 | Light-emitting element, light-emitting device, and electronic appliance | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2012-01-24 | — | — | US | disclosed |
| US-8101289-B2 | Light-emitting element, light-emitting device, and electronic appliance | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2012-01-24 | — | — | US | disclosed |
| US-20090058278-A1 | Light-Emitting Element, Light-Emitting Device, and Electronic Appliance | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. | 2009-03-05 | — | — | US | disclosed |
| US-20090058278-A1 | Light-Emitting Element, Light-Emitting Device, and Electronic Appliance | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. | 2009-03-05 | — | — | US | disclosed |
| EP-2031036-A1 | Light-emitting element, light-emitting device, and electronic appliance | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2009-03-04 | — | — | EP | disclosed |
| US-20090004506-A1 | Anthracene Derivatives and Light-Emitting Devices Using the Anthracene Derivatives | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. | 2009-01-01 | — | — | US | disclosed |
| US-20090004506-A1 | Anthracene Derivatives and Light-Emitting Devices Using the Anthracene Derivatives | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. | 2009-01-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090004506-A1 | Anthracene Derivatives and Light-Emitting Devices Using the Anthracene Derivatives | CRY1, CYP1A1, GLB1 | MAPK8 3313/4885EP300 4183/4885KAT2A 3034/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.